In this regard, a quite recent observation indicated that triple-negative expression cases (ALDH1A1-/ CD133−/mutant p53-) in lung-adenocarcinoma patients were shown to have a much better prognosis than others [52]. This evidence concerns the gene ALDH1A1 and lung adenocarcinoma.